Annual Net Margin
-12.37%
+11.71%+48.63%
December 31, 2024
Summary
- As of February 20, 2025, ALNY annual net profit margin is -12.37%, with the most recent change of +11.71% (+48.63%) on December 31, 2024.
- During the last 3 years, ALNY annual net margin has risen by +88.64% (+87.75%).
- ALNY annual net margin is now at all-time high.
Performance
ALNY Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
-14.12%
+8.15%+36.60%
December 31, 2024
Summary
- As of February 20, 2025, ALNY quarterly net profit margin is -14.12%, with the most recent change of +8.15% (+36.60%) on December 31, 2024.
- Over the past year, ALNY quarterly net margin has increased by +17.23% (+54.96%).
- ALNY quarterly net margin is now -171.71% below its all-time high of 19.69%, reached on September 30, 2023.
Performance
ALNY Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
ALNY Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +48.6% | +55.0% |
| 3 y3 years | +87.8% | +55.0% |
| 5 y5 years | +96.9% | +55.0% |
ALNY Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +88.7% | -171.7% | +90.8% |
| 5 y | 5-year | at high | +96.9% | -171.7% | +96.3% |
| alltime | all time | at high | +99.9% | -171.7% | +99.9% |
Alnylam Pharmaceuticals Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -12.37%(-48.6%) | -14.12%(-36.6%) |
| Sep 2024 | - | -22.27%(+769.9%) |
| Jun 2024 | - | -2.56%(-80.8%) |
| Mar 2024 | - | -13.34%(-57.4%) |
| Dec 2023 | -24.08%(-77.9%) | -31.35%(-259.2%) |
| Sep 2023 | - | 19.69%(-122.7%) |
| Jun 2023 | - | -86.59%(+58.8%) |
| Mar 2023 | - | -54.53%(-11.9%) |
| Dec 2022 | -109.04%(+7.9%) | -61.93%(-59.7%) |
| Sep 2022 | - | -153.58%(+24.5%) |
| Jun 2022 | - | -123.39%(+9.5%) |
| Mar 2022 | - | -112.70%(+12.7%) |
| Dec 2021 | -101.01%(-42.0%) | -99.97%(-8.3%) |
| Sep 2021 | - | -109.00%(+26.8%) |
| Jun 2021 | - | -85.95%(-23.8%) |
| Mar 2021 | - | -112.80%(-24.2%) |
| Dec 2020 | -174.15%(-56.8%) | -148.90%(-26.0%) |
| Sep 2020 | - | -201.26%(+16.7%) |
| Jun 2020 | - | -172.40%(-5.9%) |
| Mar 2020 | - | -183.18%(-52.5%) |
| Dec 2019 | -403.24%(-60.3%) | -385.30%(+29.4%) |
| Sep 2019 | - | -297.65%(-39.4%) |
| Jun 2019 | - | -490.86%(-10.2%) |
| Mar 2019 | - | -546.39%(-45.6%) |
| Dec 2018 | -1016.58%(+86.2%) | -1005.28%(-91.5%) |
| Sep 2018 | - | -11.86 K%(+2067.7%) |
| Jun 2018 | - | -546.90%(-15.2%) |
| Mar 2018 | - | -644.84%(+71.9%) |
| Dec 2017 | -545.95%(-37.2%) | -375.03%(-47.8%) |
| Sep 2017 | - | -719.10%(-3.3%) |
| Jun 2017 | - | -743.28%(+31.3%) |
| Mar 2017 | - | -565.88%(-12.5%) |
| Dec 2016 | -869.63%(+23.2%) | -647.04%(-15.1%) |
| Sep 2016 | - | -762.37%(-26.3%) |
| Jun 2016 | - | -1034.89%(-26.2%) |
| Mar 2016 | - | -1401.96%(+16.7%) |
| Dec 2015 | -705.83%(-1.0%) | -1201.44%(-1.1%) |
| Sep 2015 | - | -1214.29%(+46.9%) |
| Jun 2015 | - | -826.52%(+201.7%) |
| Mar 2015 | - | -273.92%(+207.6%) |
| Dec 2014 | -712.79% | -89.05%(-77.8%) |
| Sep 2014 | - | -400.92%(-33.6%) |
| Jun 2014 | - | -604.17%(-80.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | -3032.54%(+916.6%) |
| Dec 2013 | -189.17%(+19.1%) | -298.30%(-9.7%) |
| Sep 2013 | - | -330.17%(+57.9%) |
| Jun 2013 | - | -209.15%(+332.6%) |
| Mar 2013 | - | -48.35%(-93.4%) |
| Dec 2012 | -158.88%(+128.1%) | -732.05%(+529.1%) |
| Sep 2012 | - | -116.37%(+87.6%) |
| Jun 2012 | - | -62.04%(+12.4%) |
| Mar 2012 | - | -55.22%(-21.0%) |
| Dec 2011 | -69.66%(+60.1%) | -69.92%(+9.8%) |
| Sep 2011 | - | -63.67%(-5.1%) |
| Jun 2011 | - | -67.06%(-13.9%) |
| Mar 2011 | - | -77.93%(+138.3%) |
| Dec 2010 | -43.50%(-8.1%) | -32.70%(-6.1%) |
| Sep 2010 | - | -34.81%(-36.7%) |
| Jun 2010 | - | -54.97%(+9.6%) |
| Mar 2010 | - | -50.17%(+71.5%) |
| Dec 2009 | -47.34%(+73.4%) | -29.26%(-22.9%) |
| Sep 2009 | - | -37.97%(-58.9%) |
| Jun 2009 | - | -92.28%(+193.1%) |
| Mar 2009 | - | -31.48%(-18.2%) |
| Dec 2008 | -27.30%(-83.7%) | -38.49%(+246.4%) |
| Sep 2008 | - | -11.11%(-79.2%) |
| Jun 2008 | - | -53.54%(+859.5%) |
| Mar 2008 | - | -5.58%(-161.2%) |
| Dec 2007 | -167.92%(+30.7%) | 9.12%(-102.8%) |
| Sep 2007 | - | -323.58%(+132.9%) |
| Jun 2007 | - | -138.96%(-53.7%) |
| Mar 2007 | - | -299.92%(+148.1%) |
| Dec 2006 | -128.51%(-82.9%) | -120.87%(+34.1%) |
| Sep 2006 | - | -90.12%(-45.2%) |
| Jun 2006 | - | -164.59%(+6.2%) |
| Mar 2006 | - | -154.98%(-83.4%) |
| Dec 2005 | -750.77%(-1.6%) | -933.70%(+23.6%) |
| Sep 2005 | - | -755.70%(-24.9%) |
| Jun 2005 | - | -1005.87%(+150.4%) |
| Mar 2005 | - | -401.70%(+86.5%) |
| Dec 2004 | -763.30%(-94.6%) | -215.42%(-54.1%) |
| Sep 2004 | - | -469.35%(-91.2%) |
| Jun 2004 | - | -5309.92%(-47.6%) |
| Mar 2004 | - | -10.14 K%(-28.7%) |
| Dec 2003 | -14.22 K% | -14.22 K%(0.0%) |
| Sep 2003 | - | -14.22 K% |
FAQ
- What is Alnylam Pharmaceuticals annual net profit margin?
- What is the all time high annual net margin for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual net margin year-on-year change?
- What is Alnylam Pharmaceuticals quarterly net profit margin?
- What is the all time high quarterly net margin for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly net margin year-on-year change?
What is Alnylam Pharmaceuticals annual net profit margin?
The current annual net margin of ALNY is -12.37%
What is the all time high annual net margin for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual net profit margin is -12.37%
What is Alnylam Pharmaceuticals annual net margin year-on-year change?
Over the past year, ALNY annual net profit margin has changed by +11.71% (+48.63%)
What is Alnylam Pharmaceuticals quarterly net profit margin?
The current quarterly net margin of ALNY is -14.12%
What is the all time high quarterly net margin for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly net profit margin is 19.69%
What is Alnylam Pharmaceuticals quarterly net margin year-on-year change?
Over the past year, ALNY quarterly net profit margin has changed by +17.23% (+54.96%)